Amplify Treatments, Testing and Advancements ETF Rating → Proof that the Musk/Bezos rivalry is about to hit a new level (From InvestorPlace) (Ad) Free GERM Stock Alerts $18.04 +0.01 (+0.06%) (As of 09:58 AM ET) Add Compare Share Share RatingsStock AnalysisChartHoldingsRatingsStock AnalysisChartHoldingsRatings Amplify Treatments, Testing and Advancements ETF Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.GERM Aggregate RatingModerate Buy2.53Holdings in GERM have an aggregate rating of Moderate Buy based on 328 analyst ratings issued in the past year covering 44 companies (94.7% of the portfolio).GERM Aggregate Price Target$30.3468.17% UpsideHigh Prediction$45.45Average Prediction$30.34Low Prediction$21.67Holdings in GERM have an aggregate price target of $30.34 and a range of $21.67 to $45.45 covering 44 companies (94.7% of the portfolio).GERM Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy13 Buy rating(s)Moderate Buy15 Moderate Buy rating(s)Hold15 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell1 Strong Sell rating(s) Ratings for Stocks Held by Amplify Treatments, Testing and Advancements ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 44 GERM Holdings Export to ExcelWeightIn ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings7.91%MRNAModerna$124.18+1.9%4 of 5 stars2.25$126.89 2.2%16Earnings ReportAnalyst ForecastAnalyst Revision6.57%IBRXImmunityBio$8.11+2.4%0 of 5 stars2.00$6.00 -26.0%1Gap Up6.49%DGXQuest Diagnostics$137.64+1.1%5 of 5 stars2.25$146.17 6.2%126.27%BNTXBioNTech$92.82+3.0%3 of 5 stars2.27$118.82 28.0%11Analyst ForecastOptions VolumeNews Coverage5.98%ALNYAlnylam Pharmaceuticals$151.38-0.6%5 of 5 stars2.59$216.19 42.8%17Earnings ReportAnalyst Forecast5.56%LHLaboratory Co. of America$202.44+0.4%5 of 5 stars2.79$243.14 20.1%143.79%QDELQuidelOrtho$43.74+2.5%5 of 5 stars2.00$61.60 40.8%7Gap Down3.67%IMCRImmunocore$60.83-0.8%3 of 5 stars2.87$80.92 33.0%15Earnings ReportAnalyst ForecastAnalyst RevisionNews Coverage3.58%PCVXVaxcyte$65.36-2.1%1 of 5 stars3.00$78.50 20.1%4Earnings ReportAnalyst ForecastNews CoveragePositive NewsGap Down3.56%DVAXDynavax Technologies$10.86-6.8%4 of 5 stars2.75$25.00 130.2%4Analyst ForecastNews CoverageGap Down3.45%BIOBio-Rad Laboratories$274.48+2.3%5 of 5 stars2.80$461.00 68.0%5Earnings ReportAnalyst Forecast3.23%VIRVir Biotechnology$9.56+0.2%3 of 5 stars2.57$33.57 251.2%7Earnings ReportAnalyst ForecastAnalyst Revision3.21%ZLABZai Lab$20.30+22.5%2 of 5 stars3.00$64.22 216.4%5Earnings ReportNews CoverageGap UpHigh Trading Volume2.54%BCRXBioCryst Pharmaceuticals$5.23+2.5%4 of 5 stars3.00$14.00 167.7%7Earnings ReportAnalyst ForecastOptions VolumeAnalyst RevisionNews Coverage2.39%OPKOPKO Health$1.25-0.4%5 of 5 stars3.00$3.17 154.4%3Earnings ReportAnalyst ForecastNews Coverage1.71%ARCTArcturus Therapeutics$27.17-0.1%2 of 5 stars3.00$61.33 125.7%7News CoverageGap Up1.57%HLVXHilleVax$14.25+5.7%3 of 5 stars3.00$30.67 115.2%3Upcoming Earnings1.56%NVAXNovavax$4.51+0.9%4 of 5 stars3.00$17.00 276.9%2Upcoming Earnings1.54%CVACCureVac$2.96+2.8%4 of 5 stars2.00$8.33 181.5%51.49%FLGTFulgent Genetics$21.22-0.2%4 of 5 stars2.00$30.00 41.4%21.10%ABUSArbutus Biopharma$2.87+1.1%2 of 5 stars3.00$4.33 51.0%31.09%ADPTAdaptive Biotechnologies$3.42+7.5%4 of 5 stars2.67$6.80 98.8%6Earnings ReportNews Coverage0.98%AZNAstraZeneca$77.46+0.6%2 of 5 stars2.57$81.00 4.6%70.98%OCGNOcugen$1.63-5.3%1 of 5 stars3.00$4.67 186.4%3Upcoming Earnings0.95%OSUROraSure Technologies$4.97-6.4%4 of 5 stars2.33$6.38 28.3%3Earnings ReportNews CoverageGap Down0.93%ALTAltimmune$7.66+7.0%1 of 5 stars2.50$15.00 95.8%4News Coverage0.88%PFEPfizer$28.00+0.5%5 of 5 stars2.38$36.00 28.6%16Options VolumeAnalyst Revision0.86%SNYSanofi$48.72+0.2%3 of 5 stars2.40$55.00 12.9%50.86%GSKGSK$44.53+0.9%3 of 5 stars2.4050.84%LLYEli Lilly and Company$774.42-0.1%5 of 5 stars2.84$757.95 -2.1%19Earnings ReportDividend Announcement0.83%MRKMerck & Co., Inc.$129.91+0.3%5 of 5 stars2.58$131.33 1.1%120.83%REGNRegeneron Pharmaceuticals$966.85+1.2%4 of 5 stars2.70$981.71 1.5%200.78%AVIRAtea Pharmaceuticals$3.98+1.3%0 of 5 stars1.001Upcoming EarningsNews Coverage0.77%ABBVAbbVie$160.77+0.2%4 of 5 stars2.77$174.31 8.4%13Earnings Report0.76%JNJJohnson & Johnson$149.60+0.4%5 of 5 stars2.46$175.86 17.6%13Analyst ForecastAnalyst Revision0.76%CRMDCorMedix$5.62-1.6%2 of 5 stars3.00$13.00 131.3%4Gap Up0.75%GILDGilead Sciences$64.70-0.3%5 of 5 stars2.39$83.69 29.3%180.74%ABTAbbott Laboratories$104.79-0.1%5 of 5 stars2.67$121.50 15.9%9Insider Selling0.72%ENTAEnanta Pharmaceuticals$12.99+1.8%3 of 5 stars2.17$19.00 46.3%6Analyst ForecastAnalyst RevisionNews Coverage0.63%INOInovio Pharmaceuticals$11.16+1.5%3 of 5 stars2.67$96.00 760.2%3Upcoming Earnings0.61%IVVDInvivyd$2.46-2.8%1 of 5 stars3.00$11.33 360.7%3Gap Up0.48%EBSEmergent BioSolutions$4.48+1.6%4 of 5 stars2.00$5.00 11.6%2Gap Up0.30%VXRTVaxart$0.71-3.4%1 of 5 stars3.00$3.00 325.4%2Upcoming EarningsNews CoverageGap Up0.22%CUECue Biopharma$1.88-1.6%4 of 5 stars3.00$8.00 325.5%4Upcoming Earnings This page (NYSEARCA:GERM) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersThis 1 Biotech Stock has been shocking the marketsHuge Alerts1970’s computer coder Issues Shocking AI WarningInvestorPlaceThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldHe Is Giving Away BitcoinCrypto Swap ProfitsDems have chosen Biden replacement?Paradigm PressGold Set to EXPLODE!Gold Safe ExchangeThe A.I. story nobody is telling you (Read ASAP)TradeSmithTrump Asset Seizure Threat Alert: Could Your Savings Be Next?American Hartford Gold Group Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Amplify Treatments, Testing and Advancements ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
